发明名称 |
ERYTHROMELALGIA TREATMENT |
摘要 |
The present invention is directed to the treatment of erythromelalgiacomprising administering to a subject in need thereof, a therapeutically effective amount of 5-(4- {[(2-fluorophenyl)methyl]oxy}phenyl)-prolinamideor a pharmaceutically acceptable salt, solvate or prodrug thereof. |
申请公布号 |
WO2016051194(A1) |
申请公布日期 |
2016.04.07 |
申请号 |
WO2015GB52885 |
申请日期 |
2015.10.02 |
申请人 |
CONVERGENCE PHARMACEUTICALS LIMITED |
发明人 |
MORISSET, VALERIE |
分类号 |
A61K31/401;A61P25/02;A61P29/00;C12Q1/68 |
主分类号 |
A61K31/401 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|